Turnstone Biologics Patents – Insights & Stats (Updated 2023)

Turnstone Biologics has a total of 52 patents globally, out of which 2 have been granted. Of these 52 patents, more than 84% patents are active. Canada, Japan and Europe is where Turnstone Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Turnstone Biologics.

Turnstone Biologics was founded in 2014. Turnstone Biologics creates novel classes of viral immunotherapies and medications that target cancer at different stages. The unique vaccinia virus platform developed by Turnstone is designed to drive antigen presentation and identification, stimulate immunological responses and modify the tumor microenvironment.

Do read about some of the most popular patents of Turnstone Biologics which have been covered by us in this article and also you can find Turnstone Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Turnstone Biologics patent portfolio.

How many patents does Turnstone Biologics have?

Turnstone Biologics has a total of 52 patents globally. These patents belong to 4 unique patent families. Out of 52 patents, 44 patents are active.

How Many Patents did Turnstone Biologics File Every Year?

Turnstone Biologics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantTurnstone Biologics Applications FiledTurnstone Biologics Patents Granted
202312
20222
202112
20206
201931

How many Turnstone Biologics patents are Active/Inactive?

Worldwide Patents

Turnstone Biologics Patent Portfolio

How Many Patents did Turnstone Biologics File in Different Countries?

Turnstone Biologics Worldwide Patent Filing

Countries in which Turnstone Biologics Filed Patents

CountryPatent
Canada4
Japan4
Europe4
Singapore3
Brazil3
India3
China3
Mexico3
Australia3
Hong Kong (S.A.R.)3
Israel3
United States of America2
Viet Nam1
Indonesia1
South Africa1
Colombia1
Chile1
Taiwan1
Malaysia1
Argentina1
Peru1
Ecuador1
Philippines1

Where are Research Centers of Turnstone Biologics Patents Located?

R&D Centers of Turnstone Biologics

Best Turnstone Biologics Patents

WO2020124274A1 is the most popular patent in the Turnstone Biologics portfolio. It has received 6 citations so far from companies like Nouscom Ag.

What Percentage of Turnstone Biologics US Patent Applications Were Granted?

Turnstone Biologics (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Turnstone Biologics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Turnstone Biologics?

Law FirmTotal ApplicationsSuccess Rate
Jones Day3100%

What are Turnstone Biologics key innovation segments?

What Technologies are Covered by Turnstone Biologics?

The chart below distributes patents filed by Turnstone Biologics in different countries on the basis of the technology protected in patents. It also represents the markets where Turnstone Biologics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Turnstone Biologics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Turnstone Biologics?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.